(19)
(11) EP 4 133 115 A1

(12)

(43) Date of publication:
15.02.2023 Bulletin 2023/07

(21) Application number: 21718089.2

(22) Date of filing: 08.04.2021
(51) International Patent Classification (IPC): 
C12R 1/35(1980.01)
C12N 15/09(1990.01)
A61K 35/00(1974.07)
(52) Cooperative Patent Classification (CPC):
C12Y 302/01052; C12N 9/24; A61K 38/00; A61K 35/74; C12R 2001/35; C12N 1/205
(86) International application number:
PCT/EP2021/059142
(87) International publication number:
WO 2021/204928 (14.10.2021 Gazette 2021/41)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 08.04.2020 EP 20382288

(71) Applicants:
  • Fundació Centre de Regulació Genòmica
    08003 Barcelona (ES)
  • Institució Catalana de Recerca I Estudis Avançats
    08010 Barcelona (ES)

(72) Inventors:
  • SERRANO PUBUL, Luis
    08950 Esplugues de Llobregat Barcelona (ES)
  • LLUCH SENAR, Maria
    08174 Sant Cugat del Vallés - Barcelona (ES)

(74) Representative: De Clercq & Partners 
Edgard Gevaertdreef 10a
9830 Sint-Martens-Latem
9830 Sint-Martens-Latem (BE)

   


(54) GENETICALLY REPROGRAMMED MYCOPLASMA BACTERIA AND USES THEREOF